BELITE BIO INC - AMERICAN DEPOSITARY SHARES
48.73
08-七月-24 15:07:34
15 分钟延时
股票
+3.23
+7.09%
今日范围
45.70 - 48.93
ISIN
N/A
来源
NASDAQ
-
06 11月 2023 08:00:00 条件 Nasdaq GlobeNewswire
-
Belite Bio Announces Presentation at the American Academy of Ophthalmology 2023 Annual Meeting
27 10月 2023 08:00:00 条件 Nasdaq GlobeNewswire
-
Belite Bio Reports Second Quarter 2023 Operational Highlights and Financial Results
08 8月 2023 22:17:28 条件 Nasdaq GlobeNewswire
-
Belite Bio to Host Webcast on August 9, 2023 to Discuss Second Quarter 2023 Financial Results
04 8月 2023 08:00:00 条件 Nasdaq GlobeNewswire
-
Belite Bio Doses First Subject in Pivotal Phase 3 PHOENIX Trial Evaluating Oral Tinlarebant for GA
27 7月 2023 17:00:00 条件 Nasdaq GlobeNewswire
-
30 5月 2023 20:49:26 条件 Nasdaq GlobeNewswire
-
30 5月 2023 16:01:00 条件 Nasdaq GlobeNewswire
-
Belite Bio Reports First-Quarter 2023 Operational Highlights and Financial Results
10 5月 2023 19:58:59 条件 Nasdaq GlobeNewswire
-
Belite Bio to Host Webcast on May 11, 2023 to Discuss First Quarter 2023 Financial Results
10 5月 2023 15:33:22 条件 Nasdaq GlobeNewswire
-
04 5月 2023 11:09:06 条件 Nasdaq GlobeNewswire
-
25 4月 2023 16:30:00 条件 Nasdaq GlobeNewswire
-
11 4月 2023 09:00:01 条件 Nasdaq GlobeNewswire
-
Belite Bio Reports Full-Year 2022 Operational Highlights and Financial Results
31 3月 2023 19:03:37 条件 Nasdaq GlobeNewswire
-
Belite Bio to Host Webcast on April 3, 2023 to Discuss 2022 Full Year Financial Results
31 3月 2023 12:57:14 条件 Nasdaq GlobeNewswire
-
18 11月 2022 08:00:00 条件 Nasdaq GlobeNewswire
-
Belite Bio to Host Key Opinion Leader Webinar on October 27, 2022 to discuss LBS-008 Interim Data
20 10月 2022 08:00:01 条件 Nasdaq GlobeNewswire
-
01 10月 2022 19:03:33 条件 Nasdaq GlobeNewswire
-
23 9月 2022 08:00:00 条件 Nasdaq GlobeNewswire
-
Belite Bio Receives Approval of LBS-008 Phase 3 Clinical Trial in China
16 9月 2022 08:00:32 条件 Nasdaq GlobeNewswire
-
Belite Bio Initiates Pivotal Phase 3 Clinical Trial of LBS-008 in Stargardt Disease in the U.S.
22 8月 2022 08:00:00 条件 Nasdaq GlobeNewswire